SHWGY (SHWGY) Stock Price & Analysis
SHWGY (SHWGY) rose 25.86% to USD 2.19 as of June 10, 2026 at 02:32 UTC, according to Nexqual real-time market data.
SHWGY last closed at USD 1.74; the session ranged USD 2.12–2.19 on volume of 1,100 shares. Market capitalization is $2.44B, with a 52-week range of USD 1.6–3.51 (PNK). Source: Nexqual, June 10, 2026 at 02:32 UTC.
Key Statistics (as of June 10, 2026 at 02:32 UTC)
| Price | USD 2.19 |
|---|---|
| Change | ▲ 25.86% (up) |
| Previous Close | USD 1.74 |
| Open | USD 2.12 |
| Day Range | USD 2.12 – 2.19 |
| 52-Week Range | USD 1.6 – 3.51 |
| Volume | 1,100 shares |
| Market Cap | $2.44B |
| Exchange | PNK |
Technical Analysis (SHWGY)
Nexqual's technical model rates SHWGY "STRONG SELL" based on 0 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 02:32 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 52.35 (neutral) |
| vs SMA50 | Above (USD 1.81) |
| MACD | -0.03 (negative) |
Analyst Ratings (SHWGY)
Wall Street analysts rate SHWGY "None", per Nexqual as of June 10, 2026 at 02:32 UTC.
| Consensus Rating | None |
|---|
Earnings (SHWGY)
Source: Nexqual, June 10, 2026 at 02:32 UTC.
Financials & Fundamentals (SHWGY)
| Total Revenue | $13.39B |
|---|---|
| Revenue Growth (YoY) | +4.50% |
| Gross Margin | +47.26% |
| Operating Margin | +9.94% |
| Profit Margin | +12.04% |
| ROE | +6.69% |
| Debt / Equity | 19.77 |
| Current Ratio | 3.78 |
| Total Cash | $9.45B |
| Total Debt | $5.10B |
| Free Cash Flow | $1.27B |
Source: Nexqual, June 10, 2026 at 02:32 UTC.
Financial Health Score (SHWGY)
Nexqual rates SHWGY's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 02:32 UTC.
| Growth | Mixed — Revenue +2.3% YoY (annual), slow |
|---|---|
| Profitability | Strong — Gross margin 47%, operating 10% |
| Balance Sheet | Strong — $9.45B cash vs $5.10B debt, net cash position |
| Cash Flow | Solid — FCF $1.27B, 9% margin |
| Efficiency | Mixed — ROE 7%, ROA 3.3% |
Ownership (SHWGY)
| Shares Outstanding | 1.11B |
|---|---|
| Float | 594.27M |
Source: Nexqual, June 10, 2026 at 02:32 UTC.
Leadership (SHWGY)
SHWGY is led by Rinan Cong (age 44), CEO & Executive Director, per Nexqual as of June 10, 2026 at 02:32 UTC.
| CEO & Executive Director | Rinan Cong (age 44) |
|---|---|
| Executive Chairman of the Board & Compliance Officer | Jing Long (age 50) |
| Executive Director | Junqiang Lu (age 51) |
| Executive Director | Daoming Wang (age 45) |
| Chief Financial Officer | Xue Feng Wu (age 47) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SHPMY | Shanghai Pharmaceuticals Holdin | USD 7.6 | ▲ 0% |
| GNGBY | Getinge AB | USD 20.29 | ▼ 0.05% |
| SKHHY | Sonic Healthcare Ltd. | USD 13.87 | ▲ 2.51% |
| EKTAY | Elekta AB | USD 5.61 | ▼ 2.09% |
| CSPCY | CSPC Pharmaceuticals Group Ltd. | USD 3.6 | ▼ 4.86% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:32 UTC. This page is informational and not investment advice.